Core Insights - The article discusses the potential for AMN Healthcare Services, Inc. to experience accelerated free cash flow growth due to shifts in US age demographics and the implementation of its WorkWise and ShiftWise solutions [1]. Company Overview - AMN Healthcare Services, Inc. is positioned to benefit from demographic changes in the US, which may lead to increased demand for its services [1]. Investment Strategy - The author emphasizes a focus on small and medium-cap companies, particularly in mature industries such as mining, oil and gas, and real estate, indicating a preference for deep value investments and dividend investing [1]. Financial Expectations - The author targets an internal rate of return of approximately 5%-7% for investments, reflecting a conservative investment approach [1].

Core Insights - AMN Healthcare has sold its Smart Square® scheduling software to symplr and entered into a commercial partnership to enhance healthcare workforce solutions [1][2][3] - The partnership aims to integrate AMN's workforce planning and analytics capabilities with symplr's operational technology, addressing the complexities of healthcare workforce management [2][3][4] - The total purchase price for the software was $75 million, with $65 million paid at closing and a $10 million note due at the end of 2026 [5] Company Overview - AMN Healthcare is a leader in total healthcare talent solutions, providing a comprehensive network of healthcare professionals and customizable workforce technologies [6] - In 2024, AMN's healthcare professionals reached nearly 15 million patients across more than 2,100 healthcare systems, including 87% of the top healthcare systems in the U.S. [6] - symplr is recognized as a leader in enterprise healthcare operations software, trusted by 9 out of 10 U.S. hospitals and over 400 health plans [7]

Core Insights - symplr has acquired Smart Square scheduling software from AMN Healthcare, enhancing its healthcare workforce and operations management capabilities [1][2] - The acquisition strengthens the symplr Operations Platform by integrating AI-driven scheduling and workforce management solutions [2][3] - symplr aims to empower healthcare organizations with actionable data and technology to improve efficiencies and patient outcomes [3][4] Company Overview - symplr is a leader in enterprise healthcare operations software, trusted by 9 out of 10 U.S. hospitals and over 400 U.S. health plans [6] - AMN Healthcare is recognized for its total talent solutions in healthcare, reaching nearly 15 million patients across more than 2,100 healthcare systems in 2024 [7] - Clearlake Capital Group and Charlesbank Capital Partners are the backing investment firms for symplr, with Clearlake managing over $90 billion in assets [9][10] Strategic Implications - The acquisition of Smart Square is expected to enhance symplr's offerings in workforce planning, analytics, and AI, addressing the complexities of healthcare staffing [5] - The partnership between symplr and AMN Healthcare aims to combine operational technology expertise with workforce solutions, benefiting customers [4][5] - The integration of Smart Square's AI capabilities is positioned to help healthcare organizations anticipate staffing needs and streamline operations [3][4]

Financial Performance & Growth - The company's LTM (Last Twelve Months) revenue as of September 30, 2022, was approximately $5.5 billion[13] - The company's LTM Adjusted EBITDA reached $895 million[82] - The company's LTM Free Cash Flow reached $550 million[87] - The company's revenue increased from $1.988 billion in FY17 to $5.481 billion LTM[82] - The company's Adjusted EBITDA margin was 16.3% LTM[82] Market Position & Strategy - The company estimates a total addressable market of approximately $46 billion[53] - The company estimates the 2022 U.S Healthcare Staffing Market is approximately $40 billion[54] - The company's revenue from Technology and Workforce Solutions was 12% of total revenue in Q3 2022[61] - The company spent $378 million with small businesses and diverse-owned companies[44] Capital Allocation & Debt - The company's total debt was $850 million as of September 30, 2022[92] - The company has $534 million in total available liquidity as of September 30, 2022[92]

Core Viewpoint - AMN Healthcare Services (AMN) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Ratings - The Zacks rating system is based on changes in earnings estimates, which are tracked through the Zacks Consensus Estimate for EPS from sell-side analysts [2]. - The Zacks rating upgrade for AMN reflects an optimistic earnings outlook, likely leading to increased buying pressure and a rise in stock price [4][6]. Impact of Institutional Investors - Changes in a company's future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with stock price movements, largely due to institutional investors adjusting their valuations based on these estimates [5]. - An increase in earnings estimates typically results in higher fair value for a stock, prompting institutional investors to buy or sell accordingly, which influences stock price movements [5]. Earnings Estimate Revisions for AMN - For the fiscal year ending December 2025, AMN is expected to earn $1.08 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 9.7% over the past three months [9]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, where Zacks Rank 1 stocks have generated an average annual return of +25% since 1988 [8]. - AMN's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [11].

Group 1 - AMN Healthcare Services (AMN) closed at $21.18, with a 2% gain over the past four weeks, and a mean price target of $27.39 suggests a 29.3% upside potential [1] - The average price targets from analysts range from $24.00 to $33.00, indicating a potential increase of 13.3% to 55.8%, with a standard deviation of $3.88 reflecting the variability of estimates [2] - Analysts show strong agreement that AMN will report better earnings than previously estimated, which is a positive indicator for potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for AMN's current year earnings has increased by 6.3% over the past month, with no negative revisions [12] - AMN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can indicate the direction of price movement [14]

Core Insights - The Zacks Rank system emphasizes earnings estimates and revisions to identify winning stocks, while also considering trends in value, growth, and momentum for strong stock picks [1][2] Value Investing - Value investing is highlighted as a preferred strategy for identifying strong stocks across various market conditions, focusing on traditional analysis of key valuation metrics to find undervalued stocks [2] AMN Healthcare Services - AMN Healthcare Services (AMN) is identified as a strong value stock, currently holding a Zacks Rank of 2 (Buy) and a Value grade of A, indicating its attractiveness to value investors [3] - AMN has a price-to-book (P/B) ratio of 1.17, which is favorable compared to the industry average P/B of 1.58, suggesting that the stock is undervalued [4] - The historical P/B ratio for AMN has ranged from a high of 2.95 to a low of 0.95, with a median of 1.40 over the past year, reinforcing its current valuation status [4] - The combination of AMN's strong earnings outlook and its valuation metrics positions it as an impressive value stock at this time [5]

Core Insights - AMN Healthcare has elected Celia Huber to its Board of Directors, bringing over 30 years of experience in healthcare strategy and governance [1][3] - Huber's expertise includes advising healthcare systems and payors on strategy, risk, and performance, aligning with AMN's mission to enhance workforce solutions [2][3] Company Overview - AMN Healthcare is recognized as a leader in total talent solutions for healthcare organizations in the U.S., focusing on solving workforce challenges to improve clinical outcomes [7] - The company offers a comprehensive network of healthcare professionals and a customizable suite of workforce technologies [7] Leadership Background - Celia Huber is a Senior Partner at McKinsey & Company, leading the Board Services Practice in North America, and has extensive experience in governance and organizational transformation [3][5] - Huber has served on various boards and committees, including the AltaMed Foundation and the California Business Roundtable, showcasing her commitment to healthcare and community service [5]

AMN Healthcare Services, Inc. (NYSE: AMN ) recently reported high demand in therapy and imaging specialties as well as certain normalization in the industry. With an overall decrease in interest expenses driven by decreases in netBased in Europe, I am an independent investor with more than a decade of experience. I research cash flow statements and unlevered free cash flow figures. My articles may include a number of assumptions about the future free cash flow of companies. Many of those assumptions are bas ...

Core Insights - The average time to schedule a physician appointment in 15 major metropolitan areas has increased by 19% since 2022 and by 48% since 2004, now averaging 31 days [1][2][3] Appointment Wait Times - The survey indicates that average wait times for various specialties are as follows: - Obstetrics/Gynecology: 42 days, up 33% since 2022 and up 79% since 2004 [9] - Gastroenterology: 40 days (newly added in 2025) [9] - Dermatology: 36.5 days, up 6% since 2022 and up 50% since 2004 [9] - Cardiology: 33 days, up 23% from 2022 and up 74% since 2004 [9] - Family Medicine: 23.5 days, up 14% since 2022 and up 16% since 2009 [9] - Orthopedic Surgery: 12 days, down 29% since 2022 and down 29% since 2004 [9] Geographic Variations - Boston has the longest average wait time at 65 days, while Atlanta has the shortest at 12 days [4] - Wait times can vary significantly by specialty and metropolitan area, with some appointments taking as long as 291 days for dermatology in Portland, Oregon [6] Physician Acceptance Rates - 82% of physicians in the surveyed metropolitan areas accept Medicare, with Boston having the highest acceptance rate at 94% and Atlanta the lowest at 68% [7] - Only 53% of physicians accept Medicaid, with Detroit having the highest acceptance at 85% and New York the lowest at 28% [7][8] Implications - The increasing wait times for physician appointments indicate a growing shortage of physicians in the U.S., particularly in densely populated areas [3][5]